| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,972 |
12,920 |
$1.51M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,816 |
4,613 |
$452K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
315 |
308 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
357 |
323 |
$22K |
| 99205 |
Prolong outpt/office vis |
172 |
168 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
214 |
195 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,078 |
3,598 |
$9K |
| 99215 |
Prolong outpt/office vis |
56 |
54 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$1K |
| 87430 |
|
1,198 |
1,147 |
$721.59 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,187 |
1,083 |
$638.79 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,182 |
1,156 |
$463.88 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
987 |
930 |
$387.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
432 |
414 |
$151.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
657 |
625 |
$140.25 |
| 90672 |
|
442 |
423 |
$70.02 |
| 99072 |
|
2,175 |
1,813 |
$65.00 |
| 99001 |
|
858 |
693 |
$58.59 |
| 81000 |
|
179 |
172 |
$13.52 |
| 81002 |
|
197 |
176 |
$11.68 |
| 99000 |
|
12 |
12 |
$9.31 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
312 |
299 |
$1.49 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
261 |
223 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
112 |
86 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$0.00 |